About
Tamrisa develops novel classes of antibiotics to treat multi-drug resistant bacterial infections and manages a portfolio of established antibiotics for global distribution to combat antimicrobial resistance.
Explore Tamrisa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.